
Read More
Mukul Agrawal-backed pharma stock jumps 4.5% after Sandoz acquisition; FII ...
From Rs 129 to Rs 916, the stock has delivered returns of around 610 per cent...

From Rs 129 to Rs 916, the stock has delivered returns of around 610 per cent...

The company has been actively expanding its product pipeline, with over 70 commercialized products a...

The stock gave multibagger returns of over 200 per cent in just 1 year and a whopping 400 per cent i...

Of significant note is the remarkable reduction in the company's debt-to-EBITDA ratio, which has und...

The stock has surged nearly 107 per cent in the last year, transforming into a multibagger stock for...